Our Commitment to Patients and Families
At AVROBIO we are working to develop safe and potentially curative therapies for people living with rare genetic diseases. We aim to understand and support the journey and unique needs of patients and their families. We value the vital work of patient organizations and seek to build partnerships toward our common goals.
The investigational gene therapies in our current product pipeline are designed for the treatment of lysosomal storage disorders:
You will find information on each of these diseases in this section of our website. Our goal is to further the awareness of the unmet treatment needs of patients living with lysosomal storage disorders and share information about new advances in gene therapies.
Sign up here to receive information about AVROBIO.
To keep up to date on press releases with progress on our therapeutic programs, please fill out the information below. Thank you!